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Histamine has been reported to play an important role in pathogenesis of bronchial asthma. However, H1-blockers are not recommended as theˆrst drug for asthma therapy in the guidelines. Histamine may play various roles in allergic airway in‰ammation through the H1 receptor (H1R), H2R, and H4R in immune cells including T lymphocytes and dendritic cells. We therefore evaluated its role in allergic airway in‰ammation with the use of histamine-deˆcient mice. The results suggested that histamine plays a role in the prevention of goblet cell hyperplasia. Organic cation transporter-3 (OCT-3) is thought to be a transporter of histamine. Polymorphism of OCT-3 {R120R (T/C)} was associated with the severity of asthma. Recently, it has been proposed that both asthma and allergic rhinitis should be treated as a single airway disease. Comorbidity of asthma and allergic rhinitis is very high (70 80％) and they share similar allergic in‰amma-tion. H1-blockers are recommended asˆrst-line drugs to treat allergic rhinitis in the guidelines. Therefore H1-blockers are strongly recommended for patients with both asthma and allergic rhinitis. The histamine concentration in BALF from the patients with atopic bronchial asthma is signiˆcantly higher compared to those of the patients with allergic rhinitis and healthy controls. (p＜0.05; Tukey-Kramer Test).
Fig. 2. EŠects of Terfenadine on Airway Obstruction Induced by Histamine and Allergen
Terfenadine (180 mg) inhibited bronchial contraction by histamine completely and reduced airway obstruction by antigen inhalation signiˆcant-ly. 
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